Genor Biopharma Holdings Limited (HKG:6998)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.540
0.00 (0.00%)
Jun 6, 2025, 4:08 PM HKT
98.44%
Market Cap 1.32B
Revenue (ttm) 219.46M
Net Income (ttm) -54.57M
Shares Out 521.23M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 446,000
Average Volume 1,267,850
Open 2.540
Previous Close 2.540
Day's Range 2.500 - 2.570
52-Week Range 1.030 - 3.250
Beta 0.66
RSI 53.19
Earnings Date May 28, 2025

About Genor Biopharma Holdings

Genor Biopharma Holdings Limited, a biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally. The company’s principal drug candidates include GB242, an infliximab (Remicade) biosimilar for rheumatoid arthritis, ankylosing spondylitis, psoriasis, adult ulcerative colitis, and Crohn’s disease; GB491 (lerociclib), an oral CDK4/6 inhibitor for breast cancer; and GB492, a stimulator of interferon genes combined with GB226, currently under Phase 1/2 clinical trial to treat solid t... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 24
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6998
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.